Clinical trial
Carbon Ion Re-Radiotherapy in Patients With Recurrent or Progressive Locally Advanced Head-and-Neck Cancer: A Phase-II Study to Evaluate Toxicity and Efficacy
NCT04185974 is registered in ClinicalTrials.gov with University Hospital Heidelberg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Carbon Ion Re-Radiotherapy in Patients With Recurrent or Progressive Locally Advanced Head-and-Neck Cancer: A Phase-II Study to Evaluate Toxicity and Efficacy
- Lead sponsor
- University Hospital Heidelberg
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 25, 2020
- Completion date
- January 30, 2031
- Enrollment
- 72 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
locally advanced head-and-neck cancer